How Menopause Affects Lipid Metabolism in the Visceral Fat Depots
NCT ID: NCT02524457
Last Updated: 2015-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2015-09-30
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aging, Exercise, and Hormonal Influences of Fat Metabolism
NCT00100451
Differences in Extracellular Vesicles From Adipose Tissue of Individuals With Obesity.
NCT06444646
Human Mitochondrial Stress-driven Obesity Resistance
NCT06080568
Evaluation of the Association Between the Menstrual Cycle and Weight Loss in Healthy, Overweight Premenopausal Women
NCT01622114
Transcriptional Changes in Isolated Human Adipocytes During Obesity
NCT06907212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
maximally 1 month before- or after the operation the subject will meet at the lab for further testing, including:
* Health examination
* Blood samples
* OGTT
* DXA scan
* VO2 max testing
* MRI of the abdomen
* hyperinsulinemic euglycemic clamp
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premenopausal
Premenopausal women going through gynecological surgery
This is an observational study. There are no interventions
Postmenopausal
Postemnopausal women going through gynecological surgery
This is an observational study. There are no interventions
Postmenopausal + HT
Postmenopausal women going through gynecological surgery who has been taking hormone treatment through the past year (as a minimum)
This is an observational study. There are no interventions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
This is an observational study. There are no interventions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 45-55 years old
* for HT treated women (HT more than 1 year)
Exclusion Criteria
* chronic disease
* claustrophobia
* smoking
* Alcoholic intake \> 14 servings
* hysterectomy before menopause
* oophorectomized
* early menopause (before 40 yrs)
* BMI \> 30
45 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anders Rasmussen Rinnov
MD, phd-student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie Abildgaard, MD
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet, Denmark
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Abildgaard J, Pedersen AT, Green CJ, Harder-Lauridsen NM, Solomon TP, Thomsen C, Juul A, Pedersen M, Pedersen JT, Mortensen OH, Pilegaard H, Pedersen BK, Lindegaard B. Menopause is associated with decreased whole body fat oxidation during exercise. Am J Physiol Endocrinol Metab. 2013 Jun 1;304(11):E1227-36. doi: 10.1152/ajpendo.00492.2012. Epub 2013 Apr 2.
Abildgaard J, Henstridge DC, Pedersen AT, Langley KG, Scheele C, Pedersen BK, Lindegaard B. In vitro palmitate treatment of myotubes from postmenopausal women leads to ceramide accumulation, inflammation and affected insulin signaling. PLoS One. 2014 Jul 7;9(7):e101555. doi: 10.1371/journal.pone.0101555. eCollection 2014.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-3-2014-096
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.